HIGH TIDE INC (HITI.CA) Stock Fundamental Analysis
Canada - TSX Venture Exchange - TSX-V:HITI - CA42981E4013 - Common Stock
3.72 CAD
+0.02 (+0.54%)
We assign a fundamental rating of 4 out of 10 to HITI. HITI was compared to 32 industry peers in the Pharmaceuticals industry. HITI scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. HITI is valied quite expensively at the moment, while it does show a decent growth rate.
1. Profitability
1.1 Basic Checks
HITI had negative earnings in the past year.
HITI had a positive operating cash flow in the past year.
In the past 5 years HITI always reported negative net income.
HITI had a positive operating cash flow in 4 of the past 5 years.
1.2 Ratios
The Return On Assets of HITI (-3.76%) is better than 62.50% of its industry peers.
HITI has a Return On Equity of -6.93%. This is in the better half of the industry: HITI outperforms 68.75% of its industry peers.
HITI has a Return On Invested Capital of 4.61%. This is in the better half of the industry: HITI outperforms 78.13% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -3.76% | ||
| ROE | -6.93% | ||
| ROIC | 4.61% |
ROA(3y)-14.91%
ROA(5y)-13.84%
ROE(3y)-26.27%
ROE(5y)-34.31%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
Looking at the Operating Margin, with a value of 2.30%, HITI is in the better half of the industry, outperforming 68.75% of the companies in the same industry.
With a Gross Margin value of 25.83%, HITI is not doing good in the industry: 62.50% of the companies in the same industry are doing better.
In the last couple of years the Gross Margin of HITI has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 2.3% | ||
| PM (TTM) | N/A | ||
| GM | 25.83% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-8.25%
GM growth 5Y-5.48%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so HITI is destroying value.
The number of shares outstanding for HITI has been increased compared to 1 year ago.
HITI has more shares outstanding than it did 5 years ago.
The debt/assets ratio for HITI has been reduced compared to a year ago.
2.2 Solvency
An Altman-Z score of 3.08 indicates that HITI is not in any danger for bankruptcy at the moment.
With an excellent Altman-Z score value of 3.08, HITI belongs to the best of the industry, outperforming 87.50% of the companies in the same industry.
HITI has a debt to FCF ratio of 4.08. This is a neutral value as HITI would need 4.08 years to pay back of all of its debts.
The Debt to FCF ratio of HITI (4.08) is better than 87.50% of its industry peers.
A Debt/Equity ratio of 0.43 indicates that HITI is not too dependend on debt financing.
HITI's Debt to Equity ratio of 0.43 is in line compared to the rest of the industry. HITI outperforms 43.75% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.43 | ||
| Debt/FCF | 4.08 | ||
| Altman-Z | 3.08 |
ROIC/WACC0.56
WACC8.25%
2.3 Liquidity
A Current Ratio of 1.85 indicates that HITI should not have too much problems paying its short term obligations.
With a Current ratio value of 1.85, HITI perfoms like the industry average, outperforming 53.13% of the companies in the same industry.
HITI has a Quick Ratio of 1.29. This is a normal value and indicates that HITI is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of HITI (1.29) is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.85 | ||
| Quick Ratio | 1.29 |
3. Growth
3.1 Past
HITI shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -328.07%.
The Revenue has grown by 11.18% in the past year. This is quite good.
The Revenue has been growing by 75.59% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-328.07%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0%
Revenue 1Y (TTM)11.18%
Revenue growth 3Y42.34%
Revenue growth 5Y75.59%
Sales Q2Q%13.67%
3.2 Future
Based on estimates for the next years, HITI will show a very strong growth in Earnings Per Share. The EPS will grow by 74.44% on average per year.
HITI is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 15.74% yearly.
EPS Next Y3.81%
EPS Next 2Y103.67%
EPS Next 3Y96.71%
EPS Next 5Y74.44%
Revenue Next Year13.63%
Revenue Next 2Y21.39%
Revenue Next 3Y17.79%
Revenue Next 5Y15.74%
3.3 Evolution
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
4. Valuation
4.1 Price/Earnings Ratio
HITI reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Based on the Price/Forward Earnings ratio of 27.49, the valuation of HITI can be described as expensive.
HITI's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. HITI is cheaper than 65.63% of the companies in the same industry.
HITI is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 23.70, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 27.49 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, HITI is valued a bit cheaper than 68.75% of the companies in the same industry.
71.88% of the companies in the same industry are more expensive than HITI, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 16.48 | ||
| EV/EBITDA | 9.41 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
HITI's earnings are expected to grow with 96.71% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y103.67%
EPS Next 3Y96.71%
5. Dividend
5.1 Amount
No dividends for HITI!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
TSX-V:HITI (1/8/2026, 7:00:00 PM)
3.72
+0.02 (+0.54%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)
Earnings (Next)
Inst Owners13.66%
Inst Owner ChangeN/A
Ins Owners8.85%
Ins Owner ChangeN/A
Market Cap324.57M
Revenue(TTM)568.25M
Net Income(TTM)-9.80M
Analysts80
Price Target7.4 (98.92%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)194.66%
Min EPS beat(2)-8%
Max EPS beat(2)397.33%
EPS beat(4)1
Avg EPS beat(4)15.55%
Min EPS beat(4)-315.76%
Max EPS beat(4)397.33%
EPS beat(8)5
Avg EPS beat(8)75.15%
EPS beat(12)9
Avg EPS beat(12)61.94%
EPS beat(16)12
Avg EPS beat(16)45.88%
Revenue beat(2)1
Avg Revenue beat(2)-0.2%
Min Revenue beat(2)-1.49%
Max Revenue beat(2)1.09%
Revenue beat(4)3
Avg Revenue beat(4)0.59%
Min Revenue beat(4)-1.49%
Max Revenue beat(4)1.6%
Revenue beat(8)5
Avg Revenue beat(8)0.02%
Revenue beat(12)9
Avg Revenue beat(12)1.49%
Revenue beat(16)13
Avg Revenue beat(16)7.4%
PT rev (1m)0%
PT rev (3m)0.87%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)14.29%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.1%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 27.49 | ||
| P/S | 0.57 | ||
| P/FCF | 16.48 | ||
| P/OCF | 11.1 | ||
| P/B | 2.3 | ||
| P/tB | 6.25 | ||
| EV/EBITDA | 9.41 |
EPS(TTM)-0.13
EYN/A
EPS(NY)0.14
Fwd EY3.64%
FCF(TTM)0.23
FCFY6.07%
OCF(TTM)0.34
OCFY9.01%
SpS6.51
BVpS1.62
TBVpS0.6
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -3.76% | ||
| ROE | -6.93% | ||
| ROCE | 6.4% | ||
| ROIC | 4.61% | ||
| ROICexc | 6.71% | ||
| ROICexgc | 18.48% | ||
| OM | 2.3% | ||
| PM (TTM) | N/A | ||
| GM | 25.83% | ||
| FCFM | 3.47% |
ROA(3y)-14.91%
ROA(5y)-13.84%
ROE(3y)-26.27%
ROE(5y)-34.31%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-8.25%
GM growth 5Y-5.48%
F-Score5
Asset Turnover2.18
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.43 | ||
| Debt/FCF | 4.08 | ||
| Debt/EBITDA | 1.67 | ||
| Cap/Depr | 41.17% | ||
| Cap/Sales | 1.68% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 80.65% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.85 | ||
| Quick Ratio | 1.29 | ||
| Altman-Z | 3.08 |
F-Score5
WACC8.25%
ROIC/WACC0.56
Cap/Depr(3y)28.99%
Cap/Depr(5y)34.63%
Cap/Sales(3y)1.88%
Cap/Sales(5y)2.98%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-328.07%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0%
EPS Next Y3.81%
EPS Next 2Y103.67%
EPS Next 3Y96.71%
EPS Next 5Y74.44%
Revenue 1Y (TTM)11.18%
Revenue growth 3Y42.34%
Revenue growth 5Y75.59%
Sales Q2Q%13.67%
Revenue Next Year13.63%
Revenue Next 2Y21.39%
Revenue Next 3Y17.79%
Revenue Next 5Y15.74%
EBIT growth 1Y2.97%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year424.94%
EBIT Next 3Y133.23%
EBIT Next 5Y81.43%
FCF growth 1Y38%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y51.53%
OCF growth 3YN/A
OCF growth 5YN/A
HIGH TIDE INC / HITI.CA FAQ
What is the fundamental rating for HITI stock?
ChartMill assigns a fundamental rating of 4 / 10 to HITI.CA.
What is the valuation status for HITI stock?
ChartMill assigns a valuation rating of 3 / 10 to HIGH TIDE INC (HITI.CA). This can be considered as Overvalued.
Can you provide the profitability details for HIGH TIDE INC?
HIGH TIDE INC (HITI.CA) has a profitability rating of 3 / 10.
Can you provide the expected EPS growth for HITI stock?
The Earnings per Share (EPS) of HIGH TIDE INC (HITI.CA) is expected to grow by 3.81% in the next year.